Aktie A3DH4U NAHDI MEDICAL COMPANY
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Nahdi Medical Company

Aktien

A3DH4U

SA15HG521213

4164

Markt geschlossen - Saudi Arabian S.E.
Andere Börsenplätze
 14:20:04 13.05.2024 		% 5 Tage % 1. Jan.
133,6 SAR 0,00 % Intraday Chart für Nahdi Medical Company -2,77 % -2,48 %
08.05. Nahdi Medical verzeichnet niedrigeren Nettogewinn in Q1; Umsatz steigt MT
18.03. Nahdi Medical Company meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Nahdi Medical Logs Lower Q1 Net Profit; Revenue Rises
Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2023
Nahdi Medical Posts Higher FY23 Net Profit, Revenue
Nahdi Medical Company Approves Cash Dividend Distribution for the Second Half of 2023
Nahdi Medical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
OptiBiotix says market still "volatile" but partner sales improving
Saudi Arabia healthcare group Fakeeh Care weighs IPO, appoints HSBC - sources
Nahdi Medical Company Reports Earnings Results for the Second Quarter Ended June 30, 2023
Nahdi Medical Company Reports Earnings Results for the First Quarter Ended March 31, 2023
Nahdi Medical Company Reports Earnings Results for the Full Year Ended December 31, 2022
Nahdi Medical Company Reports Earnings Results for the Third Quarter Ended September 30, 2022
Nahdi Medical Company Reports Earnings Results for the Third Quarter Ended September 30, 2022
OptiBiotix Health gets approval to sell products in Saudi Arabia
OptiBiotix Health Plc Announces Exclusive Distributor Nahdi Medical Co Has Received Approval from the Saudi Food and Drug Authority for GoFigure Shakes and Bars Containing Patented Weight Management Aid Slimbiome
Nahdi Medical Company Announces the Establishment of a New Company, Owned by its Subsidiaries
Certain Ordinary Shares of Nahdi Medical Company are subject to a Lock-Up Agreement Ending on 20-SEP-2022.
Nahdi Medical Company(SASE:4164) added to S&P Global BMI Index
Nahdi Medical Company(SASE:4164) added to S&P Pan Arab Composite
Nahdi Medical Company Announces Distribution of Cash Dividend for First Half of 2022, Payable on August 25, 2022
Nahdi Medical Company(SASE:4164) added to FTSE All-World Index
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DH4U Aktie
  4. Nachrichten Nahdi Medical Company
  5. Andere Sprachen